scPharmaceuticals buy BiotechBee
Start price
29.09.22
/
50%
€6.15
Target price
31.12.24
€8.00
Performance (%)
-23.25%
End price
10.10.22
€4.72
Summary
This prediction ended on 10.10.22 with a price of €4.72. The prediction for scPharmaceuticals disappointed with a performance of -23.25%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| scPharmaceuticals | - | - | - | - |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
According to BiotechBee what are the pros and cons of scPharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year